3.4.21.27: coagulation factor XIa
This is an abbreviated version!
For detailed information about coagulation factor XIa, go to the full flat file.
Word Map on EC 3.4.21.27
-
3.4.21.27
-
bleeding
-
thrombin
-
clot
-
platelet
-
thrombosis
-
anticoagulant
-
prothrombin
-
kallikrein
-
kininogen
-
prekallikrein
-
viii
-
hemostasis
-
venous
-
fibrinogen
-
antithrombin
-
zymogen
-
fibrinolysis
-
procoagulant
-
fibrin
-
willebrand
-
antithrombotic
-
hemophilia
-
thromboembolism
-
plasmin
-
ashkenazi
-
fxiia
-
hageman
-
coagulopathy
-
amidolytic
-
diathesis
-
haemostat
-
thrombophilias
-
leiden
-
jewish
-
antifibrinolytic
-
kaolin
-
proline-specific
-
thrombin-activatable
-
meningosepticum
-
fletcher
-
c1-inhibitor
-
thromboelastometry
-
drug development
-
tenase
-
medicine
-
basque
-
menorrhagia
-
desmopressin
-
tranexamic
-
proline-containing
-
tafi
-
recalcified
- 3.4.21.27
- bleeding
- thrombin
- clot
- platelet
- thrombosis
-
anticoagulant
- prothrombin
- kallikrein
- kininogen
- prekallikrein
- viii
-
hemostasis
- venous
- fibrinogen
- antithrombin
- zymogen
-
fibrinolysis
-
procoagulant
- fibrin
- willebrand
-
antithrombotic
- hemophilia
- thromboembolism
- plasmin
-
ashkenazi
- fxiia
-
hageman
- coagulopathy
-
amidolytic
- diathesis
-
haemostat
- thrombophilias
- leiden
-
jewish
-
antifibrinolytic
- kaolin
-
proline-specific
-
thrombin-activatable
- meningosepticum
-
fletcher
- c1-inhibitor
-
thromboelastometry
- drug development
-
tenase
- medicine
-
basque
- menorrhagia
- desmopressin
-
tranexamic
-
proline-containing
- tafi
-
recalcified
Reaction
Selective cleavage of Arg-/-Ala and Arg-/-Val bonds in factor IX to form factor IXa =
Synonyms
activated blood-coagulation factor XI, activated coagulation factor XIa, activated factor XI, activated factor XIa, activated FXI, activated plasma thromboplastin antecedent, blood coagulation factor XIa, blood-coagulation factor XI, activated, blood-coagulation factor XIa, coagulation factor XI, coagulation factor XIa, factor XI, factor XIa, factor XIa catalytic domain, FXI, FXIa, fXIaCD, More, plasma thromboplastin antecedent, prolyl endopeptidase, protease factor XIa, PTA, recombinant human FXI370-607, rhFXI370-607
ECTree
Advanced search results
Application
Application on EC 3.4.21.27 - coagulation factor XIa
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
medicine
-
activated factor XI inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug
drug development
-
activated factor XI inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug
drug development
-
activated factor XI inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug
drug development
activated factor XI inhibition as a viable method to increase the ratio of benefit to risk in an antithrombotic drug
medicine
the enzyme may be a suitable target for the development of an antithrombotic therapy
medicine
diagnosis of FXI deficiency may be considered in patients with delayed postoperative bleeding and prolonged activated partial thromboplastin time, especially in a demographically high-risk population, such as Ashkenazi Jews. Women with severe FXI deficiency and prolonged activated partial thromboplastin time can be managed with fresh frozen plasma transfusion before neuraxial anesthesia
medicine
-
therapeutically targeting FXI may offer a strategy for preventing or treating arterial thrombosis that is not associated with the high rate of hemorrhage that accompanies many currently used anticoagulants. Pharmacological FXI inhibitors may be beneficial in septic disease
medicine
treatment options for FXI-deficient patients include virus-inactivated fresh frozen plasma, plasma-derived FXI concentrates, and activated recombinant FVII. Potential role of desmopressin for either treatment of bleeding episodes or the prevention of postoperative bleeding in patients with milder FXI defects. A single desmopressin infusion is sufficient to provide an efficient perioperative hemostasis